Rekha Hemrajani, Director at BioAge Labs, Inc. (BIOA), bought 3,000 shares at $18.00 ($54K) on 2024-09-27, disclosed to the SEC on 2025-03-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALXO | BUY | 2020-07-21 | $57K | — | Filing → |